Telomir Pharmaceuticals, Inc. Contracts & Agreements
22 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (1)
- Human Resources (7)
- Intellectual Property (2)
- Real Estate (1)
- Uncategorized (2)
- Promissory Note and Loan Agreement, dated September 24, 2024, between the and The Starwood Trust (Filed With SEC on September 27, 2024)
- Employment Agreement between the Company and Erez Aminov, dated August 12, 2024 (Filed With SEC on August 13, 2024)
- Employment Agreement by and between the Company and Michelle Yanez, dated June 18, 2024 (Filed With SEC on June 24, 2024)
- Description of Securities (Filed With SEC on March 29, 2024)
- Representatives Warrant, dated February 13, 2024 (Filed With SEC on February 13, 2024)
- Underwriting Agreement, dated as of February 8, 2024, by and among the Company, Kingswood Investments, division of Kingswood Capital Partners, LLC and the other underwriters named... (Filed With SEC on February 13, 2024)
- Form of Common Stock Purchase Warrant, by and between the Company and certain investors from January 2023 through March 2023 (Filed With SEC on December 19, 2023)
- Form of Representatives Warrant (Filed With SEC on December 19, 2023)
- Form of Underwriting Agreement (Filed With SEC on December 19, 2023)
- Debt Conversion Agreement, dated November 30, 2023, between Telomir Pharmaceuticals, Inc., and MIRALOGX LLC (Filed With SEC on December 14, 2023)
- Debt Conversion Agreement, dated November 30, 2023, between Telomir Pharmaceuticals, Inc., and the Bay Shore Trust (Filed With SEC on December 14, 2023)
- Agreement for Shared Lease Costs, dated April 1, 2023, between Telomir Pharmaceuticals, Inc., MIRALOGX LLC, and MIRA Pharmaceuticals, Inc (Filed With SEC on December 14, 2023)
- Promissory Note and Loan Agreement, dated June 15, 2023, by and between Telomir Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on December 14, 2023)
- Amended and Restated Employment Agreement, dated December 11, 2023, between Telomir Pharmaceuticals, Inc. and Nathen Fuentes, CPA (Filed With SEC on December 14, 2023)
- Form of Indemnification Agreement (Filed With SEC on December 14, 2023)
- Form of Stock Option Award under 2023 Omnibus Incentive Plan (Filed With SEC on December 14, 2023)
- 2023 Omnibus Incentive Plan (Filed With SEC on December 14, 2023)
- Common Stock Purchase Warrant, dated June 15, 2023, between Telomir Pharmaceuticals, Inc. and Bay Shore Trust (Filed With SEC on December 14, 2023)
- Amended and Restated License Agreement, dated August 11, 2023, by and between Telomir Pharmaceuticals, Inc. and MIRALOGX LLC (Filed With SEC on November 14, 2023)
- Employment Agreement, effective as of the date of the closing of the initial public offering, between Telomir Pharmaceuticals, Inc. and Dr. Christopher Chapman, Jr., MD (Filed With SEC on November 14, 2023)
- Employment Agreement, dated September 21, 2023, between Telomir Pharmaceuticals, Inc. and Nathen Fuentes, CPA (Filed With SEC on November 14, 2023)
- Amendment No. 1 to Amended and Restated License Agreement, dated November 10, 2023, by and between Telomir Pharmaceuticals, Inc. and MIRALOGX LLC (Filed With SEC on November 14, 2023)
